Sunday May 19, 2019
Home Uncategorized More men with...

More men with breast cancer removing unaffected breast: Study

0
//

Washington: Men with breast cancer who underwent surgery to remove the unaffected breast nearly increased in 2004-2011, says a new study. download

Lead researcher Ahmedin Jemal, vice president of surveillance and health services research at the American Cancer Society said “Health care providers should be aware that the increase we have seen in removal of the unaffected breast is not limited to women”

Breast cancer in men is rare, accounting for only about one percent of all cases in the US.

In women (particularly younger women), the use of contralateral prophylactic mastectomy (CPM) surgery to remove the unaffected breast, has increased.

The percentage of women with invasive breast cancer in one breast undergoing the surgery increased from about 2.2 percent in 1998 to 11 percent in 2011, the study said.

This increase has occurred despite the lack of evidence for a survival benefit from treatment, along with associated costs and possible complications.

To explore whether the same increase was occurring among men, the researchers looked at treatment among 6,332 men who underwent surgery for breast cancer limited to one breast between 2004 and 2011.

The researchers found the rates of CPM among men nearly doubled between 2004 and 2011, from three percent to 5.6 percent.

“Doctors should carefully discuss with their male patients the benefits, harms, and costs of this surgery to help patients make informed decisions about their treatments,” Jemal noted.

The findings appeared in the journal JAMA Surgery.

(with inputs from IANS)

Next Story

Jury Grants $2 Billion to Couple Claiming ‘Glysophate’ in Roundup Weed Killer Caused Cancer

Vietnam said it would stop importing Roundup and other weed killers with the ingredient

0
cancer
FILE - Containers of Roundup are displayed on a store shelf in San Francisco, Feb. 24, 2019. VOA

For the third time in less than a year, a jury has ruled the main ingredient in a popular weed killer caused cancer in its users. A San Francisco jury Monday awarded more than $2 billion to a couple in their 70s who say glyphosate in Roundup weed killer gave them non-Hodgkin lymphoma.

The couple say they used Roundup for 35 years. Attorneys for the couple say numerous scientific studies show glyphosate led to cancer in both animal and human populations.

The World Health Organization has classified glyphosate as “probably carcinogenic to humans” and last month, Vietnam said it would stop importing Roundup and other weed killers with the ingredient.

cancer
The World Health Organization has classified glyphosate as “probably carcinogenic to humans”. Pixabay

Bayer, Roundup’s manufacturer, argued that hundreds of other scientific tests show glyphosate is safe and that the U.S. Environmental Protection Agency determined that when used as directed, glyphosate is not dangerous.

ALSO READ: ‘Canine Brucellosis’- A Dog Disease which can Hit Humans in Iowa

Bayer says it is disappointed by Monday’s verdict and plans to appeal. Two other juries in March and last August awarded multimillion-dollar settlements to Roundup victims, and thousands of other cases are pending against the company.

The Wall Street Journal reports the price of shares in Bayer has dropped 30% since its first courtroom defeat in August. The newspaper also says shareholders are angered the German-based company bought Monsanto last year when it sells a product suspected of causing cancer. (VOA)